Tag: smoking cessation

1. In this randomized trial, abrupt smoking cessation was more likely to lead to lasting smoking abstinence than gradual smoking cessation. 2. Participants who preferred gradual cessation were significantly less likely to be abstinent after 4 weeks than participants who preferred abrupt cessation. Evidence Rating Level: 1 (Excellent) Study Rundown: Quitting smoking...
1. Amongst Swedish university students who smoked cigarettes and were interested in quitting, using the NEXit motivational text messaging program doubled the rate of self-reported smoking abstinence (with occasional lapses) and improved complete smoking cessation, though to a lesser degree. 2. Motivational text messaging may have a unique role amongst...
1. No differences in smoking cessation rates were detected between patients who received nicotine patch monotherapy, combined nicotine patch and lozenge therapy, or varenicline, 6 months and 1 year after follow-up. 2. Both combination nicotine replacement therapy and varenicline were superior to nicotine patch monotherapy in reducing withdrawal symptoms. Evidence Rating...
1. From a systematic review, behavioral counseling, bupropion, nicotine replacement therapy and varenicline resulted in increased rates of smoking cessation, with varenicline demonstrating the greatest effect. 2. For pregnant smokers, behavioral interventions for smoking cessation were associated with higher birth weight and less preterm birth in addition to increased rates...
1. Although lung cancer screening gave patients the opportunity to reevaluate their health, routine screening may also lower a patient’s motivation for smoking cessation. 2. A concerning misperception amongst smokers is the belief that undergoing imaging testing yields the same benefits as smoking cessation. Evidence Rating Level: 3 (Fair) Study Rundown: The...
1. Transdermal nicotine patch therapy for 24 weeks as compared to the standard 8-week regimen increased the likelihood of smoking abstinence at 24 weeks. 2. Continuation of nicotine patch therapy to 52 weeks, while safe, did not increase smoking abstinence rates significantly compared to therapy for 8 weeks or 24...
1. When compared to placebo, varenicline use for 24 weeks significantly increased smoking cessation rates at 3 months and 1 year. 2. Although clinical guidelines suggest quitting abruptly, varenicline may be a treatment option for patients with whom this is not an option. Evidence Rating Level: 1 (Excellent) Study Rundown: According to...
1. In a population of smokers who failed to respond to standard varenicline dosage, an increased dosing regimen of varenicline had no effect on the frequency of urges to smoke, the strength of urges, or the severity of withdrawal symptoms, as compared to placebo. 2. There was a reduction in...
In this section, we highlight the key high-impact studies, updates, and analyses published in medicine during the past week. Cytisine versus Nicotine for Smoking Cessation When compared with placebo, cytisine, a partial nicotinic acetylcholine receptor agonist, has been shown to nearly double the chance of smoking cessation at 6 months. This...
1. A proactive smoking cessation strategy, which consisted of telephone counseling, nicotine replacement therapy, and removal of community barriers, increased odds of smoking cessation by twice as much as standard care. 2. When each component of the intervention was analyzed, telephone therapy with a tobacco treatment specialist and use of...